Real-World Data Collection of GORE Devices Used In the Endovascular Treatment of Aortic Aneurysms Which Incorporate Visceral Arteries.

Inclusion Criteria: 1. Informed Consent Form (ICF) is signed by Subject. 2. Age ≥ 18 years at time of informed consent signature. 3. Patient presents with thoracoabdominal, pararenal, juxtarenal, or short-neck infrarenal aortic pathology suitable for endovascular repair. 4. Patient requires the incorporation of ≥ 1 visceral artery and is suitable for use of at least 1 GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis (BXB) as a bridging stent (Note: Up to six (6) visceral arteries may be incorporated). 5. Patient is willing to adhere to the institutional standard of care follow-up. Exclusion Criteria: 1. Patient has a prior visceral artery stenting not associated with registry procedure. 2. Patient treated for acute or sub-acute dissection, \<90 days from onset of symptoms 3. Patient is intended to be treated with a parallel grafting (e.g., chimney, periscope, sandwich) or octopus technique. 4. Known hypersensitivity to heparin or a previous incident of Heparin-Induced Thrombocytopenia (HIT) type II. 5. Patient has known coagulation disorders including hypercoagulability that are not amenable to treatment. 6. Patient has a life expectancy \< 1-year. 7. Patient is participating in an investigational study which may confound registry results, unless approved by Gore